Hematopoietic growth factors: A promising future for use in bone marrow dysfunction: Postgraduate Medicine: Vol 91, No 8

Views

CrossRef citations to date

Altmetric

Preview

Recombinant DNA technology has led to the development of hematopoietic growth factors, which have proven effective in various disorders characterized by bone marrow dysfunction. These factors stimulate bone marrow cells, increasing proliferative and maturation activity. The authors describe properties of these agents, discuss which are commercially available and which are undergoing animal studies, and summarize their present and probable future roles in clinical medicine.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Hematopoietic growth factors

A promising future for use in bone marrow dysfunction

Information for

Open access

Opportunities

Help and information

Hematopoietic growth factors

A promising future for use in bone marrow dysfunction

Preview

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature